Standard medical care waits for symptoms. A full-body MRI doesn't — it images you head to pelvis with no radiation and no contrast, looking for the things that kill people quietly: tumors, aneurysms, and organ disease years before they announce themselves. For people who plan to be around in 2100, it's become the default first move.
It's also genuinely useful, which is rarer in this field than you'd hope. So let's be precise about what it does, what it doesn't, what it costs, and where to actually get one.
What it catches
A whole-body MRI is a screening tool, strongest at detecting solid-organ and structural problems: many cancers (brain, liver, kidney, pancreas, ovarian), aneurysms, masses, and significant degenerative disease. Prenuvo's own dataset reports finding a clinically significant, potentially life-altering condition in a low-single-digit percentage of asymptomatic scans — small in absolute terms, enormous if it's you.
What it's not: it doesn't see most early-stage hollow-organ cancers (colon, lung micro-nodules), it isn't a substitute for a colonoscopy or a coronary calcium score, and it can't read your bloodwork. It's one instrument on the panel, not the whole panel.
The honest downside: incidentalomas
Scan a healthy person in enough detail and you will find something — a benign cyst, a harmless nodule, an ambiguous shadow. These "incidentalomas" are the real cost of whole-body screening: they trigger follow-up scans, biopsies, anxiety, and occasionally procedures for things that would never have hurt you.
This isn't a reason to skip it. It's a reason to get scanned somewhere that reads results conservatively and has a physician who'll tell you when the right move is to do nothing. The quality of the read matters as much as the quality of the magnet.
Where to get one, and what it costs
Ezra — the focused whole-body MRI specialist, roughly $1,950–$2,350 a scan depending on coverage, with a fast, consumer-friendly process and AI-assisted reads. Good entry point.
Prenuvo — the best-known name, with a one-hour whole-body protocol and a large published screening dataset. Priced in a similar band to Ezra, more locations in major US metros.
Fountain Life — bundles whole-body MRI into a broader diagnostic membership (imaging plus bloodwork, genomics, and cardiac), so the MRI isn't sold standalone but as part of an annual program in the five-figure range.
Human Longevity Inc — the deep-diagnostics pioneer (San Diego), pairing MRI with whole-genome sequencing and a full imaging battery; an annual membership commonly runs $8K–$19K.
Biograph — a newer, high-end diagnostic clinic (Silicon Valley, NYC) building the full-battery model around imaging and advanced testing.
As a rule: $2,000–$2,500 buys you a standalone scan; $8,000+ buys you a scan embedded in a program that interprets it alongside everything else. Which is right depends on whether you want a one-off look or ongoing management — see our longevity clinic cost breakdown.
Is it worth it?
For an asymptomatic person under 40 with no family history, the math is debatable — the incidentaloma risk is real and the catch rate is low. For people over 45, or with family history, or who simply want the baseline and can afford it, a whole-body MRI every few years is one of the more defensible diagnostic purchases in longevity medicine. It produces a baseline you can re-measure, which is the whole point.
How to choose, without the upsell
The trap is being scanned by a clinic that profits more from what the scan "finds you needing" than from the scan itself. Independent imaging first, then decide on treatment separately, keeps the incentives clean.
The 2100 terminal lists the imaging and diagnostic clinics above with their focus, locations, and price tiers. If you want help picking the right one for your age, history, and city — and a real intake rather than a sales queue — get matched with a clinic. It's free; the clinic pays us, not you.
Prices are 2026 estimates and vary by location and coverage — confirm with the provider before booking. Compare imaging clinics on the live 2100 terminal.
Intelligence on the longevity frontier
Weekly, free. New intake openings, trial results, and price moves — straight to your inbox.